Oturum Aç

Russell Spencer-Smith

Department of Cell and Molecular Pharmacology and Experimental Therapeutics,
Hollings Cancer Center

BIOGRAPHY

Russell Spencer-Smith has not added Biography.

If you are Russell Spencer-Smith and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.

Oncogene Apr, 2019 | Pubmed ID: 30573767

Correction: Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.

Oncogene May, 2019 | Pubmed ID: 30710144

Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.

Cell reports Feb, 2022 | Pubmed ID: 35139380

INSTITUTIONS

Medical University of South Carolina

National Cancer Institute-Frederick

JOVE ARTICLES

Russell Spencer-Smith^1,2,3

¹Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina,

²Hollings Cancer Center, Medical University of South Carolina,

³Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick

Biochemistry

Gizlilik

Kullanım Şartları

İlkeler

Bize Ulaşın

KÜTÜPHANEYE TAVSİYE ET

JoVE HABER BÜLTENLERİ

Araştırma

Eğitim

Yazarlar

Kütüphaneciler

JoVE Hakkında